Design Therapeutics, Inc. (DSGN) — 10-Q Filings
All 10-Q filings from Design Therapeutics, Inc.. Browse 7 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (7)
-
Design Therapeutics Files Q1 2026 10-Q
— Apr 28, 2026 Risk: low
Design Therapeutics, Inc. filed its quarterly report on Form 10-Q for the period ending March 31, 2026. The filing includes financial statements and other discl -
Design Therapeutics' Losses Widen Amid R&D Surge
— Nov 5, 2025 Risk: high
Design Therapeutics, Inc. (DSGN) reported a significant increase in net losses for the nine months ended September 30, 2025, reaching $53.795 million, up from $ -
Design Therapeutics' Q2 Net Loss Widens to $26.8M Amid R&D Spend
— Aug 7, 2025 Risk: high
Design Therapeutics, Inc. reported no revenue for the three and six months ended June 30, 2025, consistent with its pre-commercial stage. The company experience -
Design Therapeutics Q1 2025 Update
— May 7, 2025 Risk: medium
Design Therapeutics, Inc. filed its quarterly report for the period ending March 31, 2025. The company reported on its financial position and business activitie -
Design Therapeutics Files 10-Q for Q3 2024
— Nov 7, 2024 Risk: medium
Design Therapeutics, Inc. filed its 10-Q for the period ending September 30, 2024. The company reported its financial results and provided updates on its busine -
Design Therapeutics Files Q2 2024 10-Q
— Aug 5, 2024 Risk: medium
Design Therapeutics, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported its financial results and provided updates on its business op -
Design Therapeutics, Inc. Files 10-Q for Period Ending March 31, 2024
— May 8, 2024 Risk: low
Design Therapeutics, Inc. (DSGN) filed a Quarterly Report (10-Q) with the SEC on May 8, 2024. Design Therapeutics, Inc. filed a 10-Q report for the period endin
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX